Exploiting Cytokine Biology and Strategies for Using Non-TNF Agents in Clinical Practice Training
- : Sydney NSW 2000
Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting 1% of the population, which if left untreated can lead to joint destruction and a host of systemic complications. This module explores novel treatment approaches for RA through newly developed medications including IL-6 inhibitors, and their effectiveness in clinical practice.
Upon completion of this module the participant should be able to:
- Describe the role of cytokines, particularly IL-6, in the pathogenesis and treatment of RA
- Identify patients with RA in whom an IL-6 inhibitor, or other non-TNFi therapy, may be an appropriate strategy
- Describe new and emerging biologic therapies for RA
- Integrate strategies to address patient safety concerns and adverse events associated with TNF inhibitors